CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology® (CST) where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Hallmarks of Cancer: Sustaining Proliferative Signaling

Read More
All Posts

Hallmarks of Cancer: Sustaining Proliferative Signaling

Cancer cells stimulate their own growth, which means they become self-sufficient in growth signals, and no longer depend on external signals (like Epidermal Growth Factor EGF/ EGFR). Proliferation depends highly on these three important pathways: Akt, MAPK/Erk, and MTOR.

18-CEL-47850-Blog-Hallmarks-Cancer-4-Sustaining-Proliferative-Signaling

Akt, also known as Protein Kinase B (PKB), represents a family of serine/threonine protein kinases, Akt1, Akt2 and Akt3. Akt1 (v-Akt) was originally discovered as a proto-oncogene and plays a critical role in regulating diverse cellular functions, which include metabolism, growth, proliferation, survival, transcription, and protein synthesis. Akt is activated by various extracellular and intracellular signals, most involving the lipid kinase phosphoinositide 3-kinase (PI3K). It is also a major regulator of cell survival by inhibiting the apoptotic effects of signaling pathways and proteins (like FoxO1).

Mitogen activated protein kinases (MAPKs) are the central component in numerous signaling cascades that transmit growth, proliferation, and survival signals from the cell surface to the nucleus. Stimulation of receptor-tyrosine kinases (RTKs) by growth factors, engagement of integrins, or changes in cellular homeostasis (stress, etc.) promote the activation of signaling pathways involving Erk (extracellular regulated kinase), p38 MAPK, or Jnk (c-Jun N-terminal kinase). Each of these kinases, in turn, promotes activation of transcription factors such as c-Jun, Ets, Alk, and ATF resulting in cellular growth, survival, repair, and proliferation.

mTOR (mammalian target of rapamycin) is a protein kinase that functions as an ATP and amino acid sensor to balance nutrient and energy availability with cellular growth. mTOR can also be activated or inhibited by other signaling pathways involving Akt, Erk, and AMPK. mTOR in turn regulates a series of metabolic enzymes and other protein kinases that modulate lipid metabolism and biogenesis cellular growth and proliferation, and autophagy.

Learn more about the pathways and proteins involved in Sustaining Proliferative Signaling:

Checkout the complete guide to the Hallmarks of Cancer Research targets. Download the eBook Now.

The Hallmarks of Cancer are seminal manuscripts by Doctors Robert Weinberg and Douglas Hanahan and were published in Cell1. The authors proposed the idea that the complexity of cancer can be broken down into smaller subsets of underlying principles. The information here pertains to one Hallmark of Cancer, known as "Sustaining Proliferative Signaling." Other entries in this series explore the other proposed Hallmarks.

References:

  • Hanahan D, Weinberg RA (January 2000). "The Hallmarks of Cancer". Cell. 100 (1): 57–70. doi:10.1016/S0092-8674(00)81683-9
  • Hanahan D, Weinberg RA (March 2011). "Hallmarks of Cancer: the next generation". Cell. 144 (5):646-74. doi: 10.1016/j.cell.2011.02.013.
Chris Sumner
Chris Sumner
Chris Sumner was the Editor-in-Chief of Lab Expectations. When he's not reading/writing about curing disease, he's hiking in the woods, playing guitar, or searching for the world's best lobster roll.

Related Posts

The Biopharma Trends to Watch in 2023, According to CST Scientists

Technological innovation leads to a deeper understanding of the natural world and the underlying causes o...
Alexandra Foley Jan 18, 2023

SfN 2022: Ups and Downs in Neurodegenerative Research — New Tools, Models, and Technologies

In November, nearly 25,000 neuroscientists from all over the world gathered once again for the Society of...
Richard Cho, PhD Jan 6, 2023

Environmental Stewardship and 1% for the Planet Drive Global Giving at CST

Over the years, we’ve talked a lot about the importance of sustainability and corporate social responsibi...
Krystyna Hincman Dec 14, 2022